secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001193125-22-282637
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aileron Therapeutics effects 1-for-20 reverse stock split effective Nov 10, 2022
--------------------------------------------------------------------------------

- Reverse split reduces authorized common shares from 300M to 15M, then tripled to 45M.
- No fractional shares issued; stockholders get cash payment for fractional interests.
- All outstanding stock options and warrants adjusted per their terms.
- Split-adjusted trading begins on Nasdaq at market open on November 11, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312522282637/0001193125-22-282637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312522282637/d379228d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-282637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer